Apply For Grants | View Grant Details
<Create Account - Click Here>
Grants for Amyloid-Beta Antibody Treatment Trial in Mixed Dementia
GrantID: 65467
Grant Funding Amount Low: $6,700,000
Deadline: January 24, 2025
Grant Amount High: $6,700,000
Summary
The grant program assesses the safety and effectiveness of monoclonal antibody therapies targeting amyloid-beta in individuals with mild cognitive impairment and dementia. The program aims to unveil new possibilities in treating mixed dementia, focusing on Lewy Body Dementia, a condition often intertwined with amyloid-beta pathology...
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details